Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness

被引:21
作者
Juhl, CB
Schmitz, O
Pincus, S
Holst, JJ
Veldhuis, J
Porksen, N
机构
[1] Aarhus Kommune Hosp, Dept Med Endocrinol & Diabet M, DK-8000 Aarhus, Denmark
[2] Univ Copenhagen, Dept Med Physiol, DK-1168 Copenhagen, Denmark
[3] Univ Virginia, Gen Clin Res Ctr, Div Endocrinol, Charlottesville, VA USA
关键词
GLP-1; Insulin; pulsatility; insulin secretion; time series; Type II diabetes; human;
D O I
10.1007/s001250051347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. The enteric incretin hormone, glucagon-like peptide-1 (GLP-1), is a potent insulin secretagogue in healthy humans and patients with Type II (non-insulin-dependent) diabetes mellitus. In this study we assessed the impact of short-term GLP-1 infusion on pulsatile insulin secretion in Type II diabetic patients. Methods. Type II diabetic patients (n = 8) were studied in a randomised cross-over design. Plasma insulin concentration time series were obtained during basal conditions and during infusion with saline or GLP-1 (1.2 pmol/l . kg(-1) . min(-1)) on 2 separate days. Plasma glucose was clamped at the initial concentration by a variable glucose infusion. Serum insulin concentration time series were evaluated by deconvolution analysis, autocorrelation analysis, spectral analysis and approximate entropy. Results. Serum insulin concentrations increased by approximately 100% during GLP-1 infusion. Pulsatile insulin secretion was increased as measured by secretory burst mass (19.3 +/- 3.8 vs 53.0 +/- 10.7 pmol/l/ pulse, p = 0.02) and secretory burst amplitude (7.7 +/- 1.5 vs 21.1 +/- 4.3 pmol/l/min, p = 0.02). A similar increase in basal insulin secretion was observed (3.6 +/- 0.9 vs 10.2 +/- 2.2 pmol/l/min, p = 0.004) with no changes in the fraction of insulin delivered in pulses (0.50 +/- 0.06 vs 0.49 +/- 0.02, p = 0.84). Regularity of secretion was unchanged as measured by spectral analysis (normalised spectral power: 5.9 +/- 0.6 vs 6.3 +/- 0.8, p = 0.86), autocorrelation analysis (autocorrelation coefficient: 0.19 +/- 0.04 vs 0.18 +/- 0.05, p = 0.66) and the approximate entropy statistic (1.48 +/- 0.02 vs 1.51 +/- 0.02, p = 0.86). Conclusion/interpretation. Short-term stimulation with GLP-1 jointly increases pulsatile and basal insulin secretion, maintaining but not improving system regularity in Type II diabetic patients.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 27 条
[1]  
ANDERSEN L, 1993, CLIN CHEM, V39, P578
[2]  
[Anonymous], 1996, ANAL TIME SERIES INT
[3]   Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: Cholinergic control of GLP-1 secretion via muscarinic receptors [J].
Balks, HJ ;
Holst, JJ ;
vonzurMuhlen, A ;
Brabant, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :786-790
[4]   EFFICACY OF PULSATILE VERSUS CONTINUOUS INSULIN ADMINISTRATION ON HEPATIC GLUCOSE-PRODUCTION AND GLUCOSE-UTILIZATION IN TYPE-I DIABETIC HUMANS [J].
BRATUSCHMARRAIN, PR ;
KOMJATI, M ;
WALDHAUSL, WK .
DIABETES, 1986, 35 (08) :922-926
[5]   Glucagon-like peptide 1 improves the ability of the β-cell to sense and respond to glucose in subjects with impaired glucose tolerance [J].
Byrne, MM ;
Gliem, K ;
Wank, U ;
Arnold, R ;
Katschinski, M ;
Polonsky, KS ;
Göke, B .
DIABETES, 1998, 47 (08) :1259-1265
[6]   Glucagon-like peptide 1(7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling [J].
Gromada, J ;
Bokvist, K ;
Ding, WG ;
Holst, JJ ;
Nielsen, JH ;
Rorsman, P .
DIABETES, 1998, 47 (01) :57-65
[7]  
JENKINS GM, 1996, SPECTRAL ANAL ITS AP
[8]   Temporal and quantitative correlations between insulin secretion and stably elevated or oscillatory cytoplasmic Ca2+ in mouse pancreatic β-cells [J].
Jonas, JC ;
Gilon, P ;
Henquin, JC .
DIABETES, 1998, 47 (08) :1266-1273
[9]  
Juhl C, 1999, DIABETES, V48, pA245
[10]   GLUCAGONOSTATIC AND INSULINOTROPIC ACTION OF GLUCAGON-LIKE PEPTIDE I-(7-36)-AMIDE [J].
KOMATSU, R ;
MATSUYAMA, T ;
NAMBA, M ;
WATANABE, N ;
ITOH, H ;
KONO, N ;
TARUI, S .
DIABETES, 1989, 38 (07) :902-905